双调蛋白(AREG)活性蛋白

Active Amphiregulin (AREG)

AR; CRDGF; SDGF; Colorectum Cell-Derived Growth Factor; Schwannoma-Derived Growth Factor

  • 双调蛋白(AREG)活性蛋白 产品包装(模拟)
  • 双调蛋白(AREG)活性蛋白 产品包装(模拟)
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

活性实验

用法

Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Homo sapiens (Human,人) 应用(仅供研究使用,不用于临床诊断!)
APA006Hu01 双调蛋白(AREG)活性蛋白 Cell culture; Activity Assays.
RPA006Hu01 双调蛋白(AREG)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAA006Hu01 双调蛋白(AREG)多克隆抗体 WB; IHC; ICC; IP.
MAA006Hu22 双调蛋白(AREG)单克隆抗体 WB; IHC; ICC; IP.
MAA006Hu24 双调蛋白(AREG)单克隆抗体 WB; IHC; ICC; IP.
MAA006Hu26 双调蛋白(AREG)单克隆抗体 WB; IHC; ICC; IP.
LAA006Hu76 双调蛋白(AREG)单克隆抗体(生物素标记) WB; IHC; ICC.
SEA006Hu 双调蛋白(AREG)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA006Hu 双调蛋白(AREG)检测试剂盒(化学发光免疫分析法) Chemiluminescent immunoassay for Antigen Detection.
PSA006Hu01 双调蛋白(AREG)抗体对 ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSA006Hu01 双调蛋白(AREG)检测试剂盒DIY材料(酶联免疫吸附试验法) Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志 参考文献
Onkologie Amphiregulin and Epiregulin Expression in Colorectal Carcinoma and the Correlation with Clinicopathological Characteristics [Karger: 315380]
Br J Cancer. Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer. [Pubmed:24800946]
Cancer Sci Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancer [PubMed: 25707609]
J Cancer Res Clin Oncol Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancer [PubMed: 26195282]
Oncotarget.  Serum level of hepatocyte growth factor is a novel marker of predicting theoutcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancer [Pubmed:26716644]
留言咨询